CAR T therapy extends its reach to autoimmune diseases.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 36423579.
- Also identified by DOI 10.1016/j.cell.2022.10.026 and PMC identifier 13041721.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
CAR T therapy has revolutionized the treatment of hematologic cancers. In their recent Nature Medicine paper, Mackensen et al. report the use of CAR T cells to treat systemic lupus erythematosus in five patients. This provides enthusiasm to further explore CAR T therapy beyond oncology.
Medical subject headings
- Receptors, Chimeric Antigen
- Autoimmune Diseases
- Lupus Erythematosus, Systemic